Pages that link to "Q33560423"
Jump to navigation
Jump to search
The following pages link to Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders (Q33560423):
Displaying 50 items.
- Production of Embryonic and Fetal-Like Red Blood Cells from Human Induced Pluripotent Stem Cells (Q21560913) (← links)
- Current Management of Alcoholic Hepatitis and Future Therapies (Q26746544) (← links)
- Site-Specific Genome Engineering in Human Pluripotent Stem Cells (Q26747006) (← links)
- Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases (Q26750384) (← links)
- Induced Pluripotent Stem Cell as a New Source for Cancer Immunotherapy (Q26750579) (← links)
- hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine (Q26751506) (← links)
- Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges (Q26775061) (← links)
- An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs (Q26775122) (← links)
- Advances in cellular technology in the hematology field: What have we learned so far? (Q26853179) (← links)
- Induced pluripotent stem cells as a disease modeling and drug screening platform (Q26865689) (← links)
- Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe application (Q26866409) (← links)
- Induced pluripotent stem cell (iPSCs) and their application in immunotherapy (Q26996540) (← links)
- Stem cell sources for vascular tissue engineering and regeneration (Q27028106) (← links)
- Generation of Functional Cardiomyocytes from Efficiently Generated Human iPSCs and a Novel Method of Measuring Contractility (Q27301480) (← links)
- Stem Cells: Potential Therapy for Neonatal Injury? (Q28082268) (← links)
- Induced pluripotent stem cell potential in medicine, specifically focused on reproductive medicine (Q28083057) (← links)
- A Defined, Feeder-Free, Serum-Free System to Generate In Vitro Hematopoietic Progenitors and Differentiated Blood Cells from hESCs and hiPSCs (Q28477450) (← links)
- Generation of healthy mice from gene-corrected disease-specific induced pluripotent stem cells (Q28478987) (← links)
- Heterozygous and homozygous JAK2(V617F) states modeled by induced pluripotent stem cells from myeloproliferative neoplasm patients (Q28533511) (← links)
- Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34 progenitors (Q28730417) (← links)
- Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes (Q28750802) (← links)
- Efficient generation of nonhuman primate induced pluripotent stem cells (Q30502017) (← links)
- Human finger-prick induced pluripotent stem cells facilitate the development of stem cell banking. (Q30577389) (← links)
- Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling (Q33409483) (← links)
- Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients (Q33414617) (← links)
- Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents (Q33420698) (← links)
- Establishment of induced pluripotent stem cells from normal B cells and inducing AID expression in their differentiation into hematopoietic progenitor cells. (Q33687796) (← links)
- Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells (Q33894805) (← links)
- Qualitative and quantitative comparison of the proteome of erythroid cells differentiated from human iPSCs and adult erythroid cells by multiplex TMT labelling and nanoLC-MS/MS (Q33895201) (← links)
- Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome (Q33910479) (← links)
- Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases (Q33930452) (← links)
- The elite and stochastic model for iPS cell generation: Multilineage‐differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells (Q34032363) (← links)
- Reprogramming of T cells from human peripheral blood (Q34034432) (← links)
- Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes (Q34078669) (← links)
- Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells (Q34162877) (← links)
- Reconstructing blood from induced pluripotent stem cells (Q34175573) (← links)
- Induced pluripotent stem cells — opportunities for disease modelling and drug discovery (Q34231818) (← links)
- Human-Induced Pluripotent Stem Cells: In Quest of Clinical Applications (Q34251675) (← links)
- Human induced pluripotent stem cells can reach complete terminal maturation: in vivo and in vitro evidence in the erythropoietic differentiation model. (Q34284032) (← links)
- Induced pluripotent stem cells: the new patient? (Q34303709) (← links)
- An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells (Q34314350) (← links)
- Generation of induced pluripotent stem cells using site-specific integration with phage integrase (Q34320340) (← links)
- A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells (Q34320565) (← links)
- Thinking outside the liver: induced pluripotent stem cells for hepatic applications (Q34353627) (← links)
- Efficient generation of functional dopaminergic neurons from human induced pluripotent stem cells under defined conditions (Q34373911) (← links)
- Investigating human disease using stem cell models (Q34431170) (← links)
- Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. (Q34463138) (← links)
- Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells (Q34550486) (← links)
- Nuclear Reprogramming Strategy Modulates Differentiation Potential of Induced Pluripotent Stem Cells (Q34619318) (← links)
- Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors (Q34738075) (← links)